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I N T R O D U C T I O N  
 
 Early recognition of patients with sepsis induced tissue 
hypoperfusion (SITH) remains a clinical challenge. 
 
 Non-Invasive tissue oxygenation saturation (StO2) 
monitors have been developed to provide a rapid, low-
cost, and non-invasive bedside assessment of tissue 
oxygenation extraction. 
 
 Use of StO2 monitors has not been well validated as an 
initial screening tool for sepsis in the ED 
 
O B J E C T I V E S 
 
 To assess the efficacy of initial bedside StO2 readings in 
the early identification of patients with SITH and to 
compare StO2 readings with lactate levels. 
 
 We hypothesize that patients with significantly abnormal 
StO2 readings will have a higher sepsis mortality and 
higher lactate levels. 
 
 
M E T H O D S 
 
 We performed an IRB-approved, prospective, 
observational pilot study of a convenience sample of ED 
patients presenting with a sepsis continuum diagnosis. 
 
 The study was conducted at an urban, tertiary care 
center with 90,000 visits per year 
 
 A portable In-Spectra ‘Spot Check’ StO2 monitor was 
used to take a StO2 reading at the thenar eminence. 
 
 We defined an abnormal StO2 as <80% or >91% based 
on consultations with the device manufacturer 
 
 Sensitivity/Specificity, Likelihood ratios, and NPV/PPV 
were calculated with 95% confidence intervals where 
appropriate. 
 
 Inclusion: Patients with a suspected new infection 
confirmed by the attending physician and at least 2 SIRS 
(systemic inflammatory response syndrome) criteria. 
 
 Exclusion: Patients <18 years of age or patients with no 





R E S U L T S 
 
Enrollment Statistics 
79 patients enrolled 
 -Mean Age: 63 (21-96) 
61 patients were admitted 
_______________________________________________________________________________________________________________________________________________________________________________ 
 
Lactate vs. Abnormal StO2 
16/20 (80%) w/Lactate >2.3 had an abnormal StO2 
7/8 (88%) w/Lactate >3.0 had an abnormal StO2 


















ICU Admissions, Mortality, and MAP vs. Abnormal StO2 
5/5 (100%) admitted to the ICU had an StO2 <74% 
3/3 (100%) of mortalities had an StO2 < 72% 






R E S U L T S 
 


















C O N C L U S I O N S 
 
 There was a strong correlation between poor patient 
outcomes and abnormal StO2  levels as well as a strong 
correlation between high lactate levels and abnormal 
StO2 levels. 
 
 StO2 may be a useful, rapid, low cost, and non-invasive 
bedside screening tool for SITH in the ED. 
 
 StO2 is particularly effective with severely ill patients. 
 
 A reliable bedside tissue oxygenation monitor will allow 
physicians and nurses to provide sepsis treatment closer 
to time zero. 
 
 Further studies are needed to determine StO2’s ability to 
predict mortality and assess response to therapy. 
 
 We will be looking at a subset of severe sepsis/septic 
shock patients using a constant monitoring StO2 monitor 
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Figure 1. Percentage of study patients with abnormal StO2 readings at                                
varying lactate levels 
























Statistical Test Statistical Value 
95% Confidence 
Interval 
Sensitivity 92.0% (77.5%-98.2%) 
Specificity 82.2% (67.9%-92.0%) 
PPV 80.5% (65.1%-91.2%) 
NPV 92.5% (80.0%-98.3%) 
+LR 5.2 (2.7-9.7) 
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